Laura G. Eichorn - 20 Jul 2022 Form 4 Insider Report for Imago BioSciences, Inc.

Role
Chief Operating Officer and CFO
Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Laura Eichorn
Issuer symbol
N/A
Transactions as of
20 Jul 2022
Net transactions value
-$15,480
Form type
4
Filing time
21 Jul 2022, 17:50:56 UTC
Previous filing
24 Feb 2022
Next filing
18 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGO Common Stock Options Exercise $2,520 +1,000 +0.48% $2.52* 208,737 20 Jul 2022 Direct F1
transaction IMGO Common Stock Sale $18,000 -1,000 -0.48% $18.00 207,737 20 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -1,000 -0.98% $0.000000 100,956 20 Jul 2022 Common Stock 1,000 $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Remarks:

Chief Operating Officer and CFO